about
sameAs
Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practiceHas CXCL13 an added value in diagnosis of neurosyphilis?Human prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.A Practical Guide to Immunoassay Method ValidationVariability of CSF Alzheimer's disease biomarkers: implications for clinical practice.Multicenter Analytical Validation of Aβ40 Immunoassays.Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorderAge and diagnostic performance of Alzheimer disease CSF biomarkers.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative Diseases.A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an exampleSerum S100B: A proxy marker for grey and white matter status in the absence and presence of (increased risk of) psychotic disorder?Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.Hourly analysis of cerebrospinal fluid glucose shows large diurnal fluctuationsMicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.CSF biomarker variability in the Alzheimer's Association quality control program.Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot StudyConsensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency.Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review.CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.GLUT1 deficiency syndrome into adulthood: a follow-up study.Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial.Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice.Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood-brain barrier.Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study.Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.Ancillary investigations to diagnose parkinsonism: a prospective clinical study.CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions.Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.Amyloid beta-42 (Aβ-42), neprilysin and cytokine levels. A pilot study in patients with HIV related cognitive impairments.Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation.Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson's disease and controls.MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.Impact of molecular imaging on the diagnostic process in a memory clinic.Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort.A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers.
P50
Q21134093-AE74D81F-A06C-43A7-9B29-E35871F8ECD7Q30399874-2FB2B3FA-4534-43DE-AAC0-9931A140A1F9Q30467870-110064E9-167F-4C40-B8B6-36A5CDAC35CBQ30661695-31C38EDB-EA7D-46E1-8F65-7D2B3F15E3D0Q33800534-02ACA290-CCBD-4F95-A871-1B2C740257ACQ33871427-C9A78943-0A6F-4F86-B31C-8C2E36F39241Q35072837-F3AF8925-0B35-4E1D-9CD8-7EE471D87430Q35758640-32210069-5B16-4BA9-B05D-8FED8261DEAAQ35800785-0D26C0AC-564E-4454-B94E-32EA2963348FQ35899066-E1AC9237-FE3D-47A3-9A43-FD4273C06F4DQ36162523-95DC59E8-58F3-4BBC-8FBD-ED6E9CC43499Q36323907-9CA304C6-FE14-461C-87BD-93D30E31236FQ36328551-793D507D-6C85-44ED-85F2-6631811B8F85Q36424500-2A4A5F91-8FB7-4FA0-9167-D02CE807B40BQ36860684-828AE1E6-AF9F-4F74-89FA-AD970FA9A87EQ36994237-9DB17FC7-89B6-4E98-A86D-B207069FA0EEQ36999855-DB52133A-E7DB-46CF-8F00-93A326D6F6E0Q37155510-EF0304EA-6BE9-4C30-BA2A-26EBEFAB3F6EQ37591499-AE50F275-B1D0-42FE-ABE3-08D8EFF43CEBQ38133736-72388F7E-28F3-4698-A6D6-D42A38B1C14DQ38145962-A49B32A3-2606-4378-910B-750125B1656EQ38177642-F62F99BF-5201-459A-8B5D-B73C673FB93FQ38429137-6FCF07B7-C390-469F-BCD2-B3E764EF727AQ38486351-E014CB6B-52CC-41E1-9A6C-8C1E37D3969BQ38603309-AC3C835B-7C52-47AA-8C14-79D308FD165AQ38636940-D2A5D010-7216-47A0-8975-A9A808165733Q38741714-C4DC3629-FC3B-4A2C-B5BE-715EF902459CQ38877405-356765CC-4B15-44C5-9CDF-A32FA54DA530Q39036392-25EFAD28-2E7E-4843-9401-97A7DD55A290Q39100999-D9406C2D-27B8-498F-9161-82F29A24949AQ40267156-A7F1DD90-3432-40D7-9E3B-285168CB4A21Q40437527-535D6A57-424B-4D4B-994B-41CDE34974A5Q40817419-792310CA-E787-4A2E-B41F-51426EFD3D08Q41027014-C89E6F44-DC24-49FE-AD40-7831D5D52320Q41878437-D9BF6C5A-3EFE-4423-9DCC-9EE4796FA0C2Q43517732-5D1C78A3-1C24-41BA-AAC9-D7B7CE979C5EQ44001848-DE5C0FC2-D1CF-4931-BE89-B504BA27CF91Q44266621-0940E485-AA26-4B61-893B-920E390C638CQ44379208-31016CAE-C36E-4798-B86A-F283EBD7FEAFQ44509433-520E9C19-C59C-4167-9F38-513E53EE210C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
M. Verbeek
@ast
Marcel M Verbeek
@es
Marcel M Verbeek
@sl
Marcel Verbeek
@en
Marcel Verbeek
@nl
type
label
M. Verbeek
@ast
Marcel M Verbeek
@es
Marcel M Verbeek
@sl
Marcel Verbeek
@en
Marcel Verbeek
@nl
altLabel
Marcel M Verbeek
@ast
Marcel M Verbeek
@en
Marcel M Verbeek
@nl
Marcel Verbeek
@en
Verbeek MM
@en
prefLabel
M. Verbeek
@ast
Marcel M Verbeek
@es
Marcel M Verbeek
@sl
Marcel Verbeek
@en
Marcel Verbeek
@nl
P1053
D-1971-2010
P106
P21
P31
P3829
P496
0000-0003-4635-7876
P569
2000-01-01T00:00:00Z